Valuation: EMVision Medical Devices Ltd

Market Cap 151M 105M 91.89M 84.77M 78.08M 147M 10.12B 1.01B 399M 4.96B 395M 386M 17.07B P/E 2026 *
-16.5x
P/E 2027 * -14.3x
Enterprise Value 151M 105M 91.89M 84.77M 78.08M 147M 10.12B 1.01B 399M 4.96B 395M 386M 17.07B EV / Sales 2026 *
27.4x
EV / Sales 2027 * 30.1x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-4.42%
1 week+7.28%
Current month+6.93%
1 month+5.19%
3 months+3.18%
6 months-10.00%
Current year-8.99%
1 week 1.47
Extreme 1.47
1.76
1 month 1.47
Extreme 1.47
1.76
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.16
Extreme 1.16
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 30/06/2023
Director of Finance/CFO - 31/01/2026
Chief Tech/Sci/R&D Officer - 30/06/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 30/06/2018
Date Insider Type Main position Quantity % Market Cap.
23/04/26 Buy

Director

10,000 0.0108%
02/01/26 Expiration

Chairman

300,000 0.3228%
18/11/25 Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-4.42%+7.28%-6.90%+36.71% 110M
-1.97%+1.48%+27.90%+0.59% 202B
-0.58%+4.01%+5.45%-15.26% 145B
-14.15%-16.07%-32.62%-2.42% 142B
-1.32%-2.13%-57.33%-16.97% 66.32B
-2.40%-6.13%+12.60%-8.19% 50.58B
-0.11%+2.15%-23.83%-32.04% 44.81B
-3.41%-1.59%+15.90%+9.78% 38.44B
-2.44%-2.16%+27.43%+36.27% 37.13B
-4.00%-2.52%-16.41%-22.92% 29.89B
Average -1.94%+2.24%-4.78%-1.45% 75.67B
Weighted average by Cap. -1.26%+1.83%-1.74%-5.78%

Financials

2026 *2027 *
Net sales 5.5M 3.84M 3.36M 3.1M 2.85M 5.38M 370M 37.03M 14.56M 181M 14.42M 14.1M 624M 5M 3.49M 3.05M 2.81M 2.59M 4.89M 336M 33.66M 13.23M 165M 13.11M 12.82M 567M
Net income -9.1M -6.35M -5.55M -5.12M -4.72M -8.9M -611M -61.26M -24.09M -300M -23.85M -23.33M -1.03B -12M -8.38M -7.32M -6.76M -6.22M -11.74M -806M -80.78M -31.76M -395M -31.46M -30.76M -1.36B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
17/07/26 A$1.620 -4.42% 30,981
16/07/26 A$1.695 -3.69% 62,245
15/07/26 A$1.760 +15.41% 34,279
14/07/26 A$1.525 +1.33% 75,809
13/07/26 A$1.505 +0.33% 32,218
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.620AUD
Average target price
3.150AUD
Spread / Average Target
+94.44%

Annual profits - Rate of surprise